Meerkat, I sort of agree but give people more credit than that....

Meerkat,

I sort of agree but give people more credit than that. If one doesn't understand the sector don't buy in it, a lesson not lost on me with ARU and Thorium.

However I think you miss the mark sometimes in regards CYP and its products (destined for Bio-techs) and its process (as a royalty based platform). What they have achieved is significant within the sector and the implications across many bio-techs is substantial.

I don't know what a blockbuster is, what I do know is that CYP, as a company, has good potential if nurtured carefully and correctly as it has a great platform and product to go to its market with, its market being the bio-techs.